SCHEMBL5756323

SCHEMBL5756323

O=c1oc(-c2cc(Cl)ccc2O)nn1-c1ccc(C(F)(F)F)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TMPRSS4 Q9NRS4 4/20 0.44
P2RX1 P51575 3/20 0.44
P2RX4 Q99571 2/20 0.44
P2RX7 Q99572 2/20 0.44
KMT2A Q03164 2/20 0.43
BIRC5 O15392 1/20 0.40
CYP2C9 P11712 4/20 0.39
CYP3A4 P08684 3/20 0.39
CYP2C19 P33261 3/20 0.39
CYP2D6 P10635 2/20 0.39
CYP1A2 P05177 1/20 0.39
MAPT P10636 1/20 0.38
MEN1 O00255 1/20 0.37
IKBKB O14920 1/20 0.37
CHUK O15111 1/20 0.37
KDR P35968 1/20 0.37
FLT3 P36888 1/20 0.37
MYLK Q15746 1/20 0.37
MAP4K5 Q9Y4K4 1/20 0.37
EPHX2 P34913 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7944175 0.84 KMT2A (0.43) KMT2ACYP2C9MAPT
SCHEMBL7944461 0.83 MAPT (0.49) KMT2ACYP2C9MAPTMEN1
SCHEMBL7954586 0.77 ATM (0.48) TMPRSS4P2RX1P2RX4P2RX7KMT2A
SCHEMBL10473995 0.70 F7 (0.47) KMT2ACYP2C9CYP3A4CYP2C19CYP1A2
SCHEMBL1261092 0.70 KIF11 (0.47) KMT2ACYP2C9MEN1IKBKBKDR
SCHEMBL7957472 0.70 MAPT (0.45) KMT2ACYP2C9CYP3A4CYP2C19CYP2D6
SCHEMBL7950909 0.70 P2RX1 (0.44) TMPRSS4P2RX1P2RX4P2RX7KMT2A
SCHEMBL5753214 0.70 NOTUM (0.41) TMPRSS4P2RX1P2RX4P2RX7KMT2A
SCHEMBL5752911 0.70 KMT2A (0.41) TMPRSS4P2RX1P2RX4P2RX7KMT2A
SCHEMBL29572389 0.70 KMT2A (0.41) TMPRSS4P2RX1P2RX4P2RX7KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0915856-A4 DIPHENYL HETEROCYCLES AS POTASSIUM CHANNEL MODULATORS BRISTOL MYERS SQUIBB CO (US) 2006-04-12 EP claimed
EP-0915856-A1 DIPHENYL HETEROCYCLES AS POTASSIUM CHANNEL MODULATORS Bristol-Myers Squibb Company (US) 1999-05-19 EP claimed
US-5869509-A TREAT DISORDERS RESPONSIVE TO OPENERS OF THE LARGE CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-02-09 US claimed
WO-1998004135-A1 DIPHENYL HETEROCYCLES AS POTASSIUM CHANNEL MODULATORS BRISTOL-MYERS SQUIBB COMPANY (US) 1998-02-05 WO claimed
EP-0915856-A4 DIPHENYL HETEROCYCLES AS POTASSIUM CHANNEL MODULATORS BRISTOL MYERS SQUIBB CO (US) 2006-04-12 EP disclosed
US-6271249-B1 Diphenyl imidazoles as potassium channel modulators BRISTOL-MYERS SQUIBB COMPANY 2001-08-07 US disclosed
US-6077861-A MODULATORS OF THE LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM (BK) CHANNELS, THEREFORE, USEFUL IN THE TREATMENT OF ISCHEMIC STROKE BRISTOL-MYERS SQUIBB COMPANY (US) 2000-06-20 US disclosed
EP-0915856-A1 DIPHENYL HETEROCYCLES AS POTASSIUM CHANNEL MODULATORS Bristol-Myers Squibb Company (US) 1999-05-19 EP disclosed
US-5869509-A TREAT DISORDERS RESPONSIVE TO OPENERS OF THE LARGE CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-02-09 US disclosed
WO-1998004135-A1 DIPHENYL HETEROCYCLES AS POTASSIUM CHANNEL MODULATORS BRISTOL-MYERS SQUIBB COMPANY (US) 1998-02-05 WO disclosed